Multimodal artificial intelligence for early cancer detection via liquid biopsy, imaging, and clinical records

Tumours are diverse and multiscale, making it difficult for modern medicine to diagnose early cancer. Using structured clinical data, radiologic imaging features, and liquid samples, this research presents a multimodal AI framework for the early and reliable detection of cancer. The proposed approach surpasses single-modality approaches by integrating signals from various domains, including cancer genetic, anatomical, and physiological data. Using attention-based fusion, representation learning, and better preprocessing, we developed a prediction model that fine-tuned the weights of different modes. The results of the experiments demonstrated that it outperformed unimodal models on all datasets in terms of sensitivity, specificity, and generalisation. The framework has potential for screening purposes because of its ability to detect cancer at an early stage. Clinical confidence and interpretability were both boosted by the results of explainability tests, which revealed substantial feature contributions. The suggested multimodal framework outperformed unimodal baselines across all assessment cohorts with an AUC of 0.94, sensitivity of 0.91, and specificity of 0.88. Experimental results confirm multimodal fusion's clinically interpretable early cancer detection and precision oncology decision assistance.